Biomedical technology

Embattled Philips says respirators 'within safety limits'

Under-fire Dutch medical device maker Philips said Wednesday extensive testing on its recalled respirator devices showed they were "within safety limits" for use, but that a final verdict rests with global regulatory authorities.

Medications

More pain for Japan's Daiichi hit by Ranbaxy fraud

Daiichi Sankyo believed it had scored a coup in 2008 when it outbid rivals to buy Indian generics giant Ranbaxy for $4.6 billion but its foray into the high-growth copycat drugs arena has brought the Japanese drugmaker only ...

Medications

Roche extends its hostile takeover bid for Illumina

Swiss pharmaceutical group Roche said Monday it is sticking by its hostile $5.7-billion (4.2 billion euros) bid for US gene mapper Illumina and is extending it for a month.

Other

Amgen buys Micromet for anti-leukemia drug

Biotech giant Amgen said Thursday it was buying the German-American cancer research firm Micromet, giving it access to Micromet's promising leukemia therapy.

page 2 from 2